Meglumine gadoterate induces immunoglobulin‐independent human mast cell activation via <scp>MRGPRX2</scp>-Reference-Cited by-同舟云学术

Meglumine gadoterate induces immunoglobulin‐independent human mast cell activation via MRGPRX2

Published:2023-08-07 Issue:12 Volume:78 Page:3255-3258
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Ruiz de Azcárate Paula H.¹^ORCID,López‐Sanz Celia¹^ORCID,López‐Raigada Azahara²,Vega Francisco²^ORCID,Jiménez‐Saiz Rodrigo¹³⁴⁵^ORCID,Blanco Carlos²

Affiliation:

1. Department of Immunology Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS‐Princesa) Universidad Autónoma de Madrid (UAM) Madrid Spain

2. Department of Allergy, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS‐Princesa) Universidad Autónoma de Madrid (UAM) Madrid Spain

3. Department of Immunology and Oncology Centro Nacional de Biotecnología (CNB)‐CSIC Madrid Spain

4. Faculty of Experimental Sciences Universidad Francisco de Vitoria (UFV) Madrid Spain

5. Department of Medicine, McMaster Immunology Research Centre (MIRC), Schroeder Allergy and Immunology Research Institute (SAIRI) McMaster University Hamilton Ontario Canada

Funder

Fundación de la Sociedad Española de Alergología e Inmunología Clínica

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15847

Reference6 articles.

1. Fast challenge tests with gadolinium‐based contrast agents to search for an alternative contrast media in allergic patients

2. MRGPRX2 in drug allergy: What we know and what we do not know

3. Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record–Linked Biobank

4. Protocol to desensitize human and murine mast cells after polyclonal IgE sensitization

5. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia